Gem Aromatics Ltd Q1 FY27 Results

Gem Aromatics reported a consolidated net loss of ₹7.87 Cr for Q1 FY27 (quarter ended June 30, 2026), reversing a ₹7.98 Cr profit a year ago and a ₹1.01 Cr profit last quarter, even as consolidated revenue grew 12.8% YoY to ₹98.85 Cr (down 10.5% QoQ from the seasonally stronger Q4). Consolidated EPS was -₹1.56 versus +₹1.70 a year ago. Standalone (parent-only) results tell a different story: revenue of ₹82.99 Cr and a profit of ₹7.25 Cr (EPS ₹1.39), only modestly below year-ago standalone profit — the entire swing to loss sits at the consolidated/subsidiary level (Gem Aromatics LLC and Krystal Ingredients Private Limited), a gap wide enough that readers comparing the two numbers should not assume either is an error.

The margin bridge is straightforward: consolidated cost of materials consumed jumped to ₹99.04 Cr — essentially all of revenue — from ₹71.62 Cr a year ago and ₹76.24 Cr last quarter, while depreciation and amortisation surged to ₹9.13 Cr from just ₹1.82 Cr YoY (and ₹9.01 Cr QoQ, so the depreciation step-up is now running at Q4 levels). Consolidated operating margin compressed to roughly 3.5% this quarter from the ~17% booked a year ago and ~14% last quarter. The depreciation jump lines up with management's own framing from the FY26 Q4 call, where the Dahej greenfield facility (peak revenue potential ₹800 Cr) was flagged for a phased ramp, concentrated in H2 — i.e., the plant is now on the books and being depreciated ahead of the volumes it is meant to generate. Auditors also flagged a change in inventory valuation from Weighted Average Cost to FIFO, applied prospectively from April 1, 2026, whose effect on the cost lines the company says is 'not ascertainable' — a caveat on comparability worth keeping in mind alongside the raw cost swing.

The stock went into the print at ₹204.5, up 25% over the past month of trading.

No formal analyst consensus for this print turned up in a search — the stock is small-cap and thinly covered, though MarketsMojo carried a 'Sell' rating on it as of July 8, 2026, and Gem Aromatics has scheduled an earnings call for August 14, 2026 where management is expected to address raw-material and freight-rate volatility and Q1 margins directly, corroborating the cost-line story here. On guidance, management explicitly deferred quarter-specific FY27 targets on the Q4 call, framing FY27 as 'significantly better than FY26, closer to FY25' on the back of Dahej and export-market stabilisation — a Q1 consolidated loss is a rough opening quarter against that framing, even allowing for the flagged H2-weighted ramp; call it a miss on trajectory so far, to be confirmed or reversed as Dahej utilisation builds. No standalone press release was available to cross-check management's own characterisation of the quarter. The quarter's other corporate actions — FY26 annual report/AGM notice dispatched July 28 for the August 19 AGM, and board approval in June for a new Brazil subsidiary and auditor reappointments — are governance-cycle items with no direct bearing on this quarter's numbers.